The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention.

Published in: ANZ journal of surgery (2023)

This study highlights areas of deficiency in prescribing of cardioprotective medication in this high-risk group. These could be targets for national quality improvement initiatives.

Keyphrases

quality improvement
peripheral artery disease
primary care
patient safety
adverse drug
randomized controlled trial
healthcare
replacement therapy
drug induced